Julie Makani/LinkedIn
May 25, 2026, 15:28
Julie Makani: African Health Science Partnerships at INTEREST 2026
Julie Makani, Science Advisor at East Central and Southern Africa Health Community, shared a post on LinkedIn:
“Meetings at the INTEREST Conference in 2026
Speakers:
- Dr Nyaradzo Mgodi, University of Zimbabwe
- Prof Julie Makani, MUHAS
Health Science in Africa: Zimbabwe and Tanzania
Discussion on potential partnership opportunities involving SickleInAfrica, ACRN, and GGTI (Global Gene Therapy Initiative), focusing on sickle cell disease (SCD) and HIV.
INTEREST 2026 in Dar-es-Salaam.
12-15 May 2026.
International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings (INTEREST Conference).”
Find more posts featuring Julie Makani on Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question